thimerosal has been researched along with Child Development Deviations in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 18 (69.23) | 29.6817 |
2010's | 8 (30.77) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abreu, L; Dórea, JG; Marques, RC | 1 |
Savoy, M | 1 |
Geier, DA; Geier, MR; Hooker, BS; Kern, JK; King, PG; Sykes, LK | 1 |
Gołoś, A; Lutyńska, A | 1 |
Fombonne, E; Meilleur, AA | 1 |
Bisiacchi, P; Chiarotti, F; D'Elia, L; De Mei, B; Salmaso, S; Tarantino, V; Tozzi, AE | 1 |
DeStefano, F | 1 |
Bernardi, JV; Dórea, JG; Marques, RC | 1 |
Dórea, JG | 2 |
Augustyniak, M; Kiełtyka, A; Majewska, R; Mrozek-Budzyn, D | 1 |
Ida-Eto, M; Narita, M; Narita, N; Ohkawara, T; Oyabu, A; Tashiro, Y | 1 |
Geier, DA; Geier, MR | 2 |
Black, SB; Chen, RT; Davis, RL; DeStefano, F; Lieu, TA; Rhodes, PH; Shinefield, H; Verstraeten, T | 1 |
Golding, J; Heron, J | 1 |
Andrews, N; Grant, A; Miller, E; Osborne, V; Stowe, J; Taylor, B | 1 |
Parker, SK; Pickering, LK; Schwartz, B; Todd, J | 1 |
Bauer, K; Keller-Stanislawski, B; Volkers, P; Weisser, K | 1 |
Gerbert, DA; Herman, LM; Larson, LW; Léger, MM; McNellis, R; O'Donoghue, DL; Ulshafer, C; Van Dyke, EM | 1 |
Bastos, WR; Bernardi, JV; Dórea, JG; Malm, O; Manzatto, AG; Marques, RC | 1 |
Benson, P; Black, S; Davis, RL; DeStefano, F; Dunn, J; Eriksen, E; Goodson, B; Hinrichsen, VL; Jackson, LA; Lewis, E; Lieu, TA; Marcy, SM; Price, C; Ray, P; Shay, DK; Stewart, G; Thompson, WW; Weintraub, ES | 1 |
Bastos, WR; Bernardi, JV; Dórea, JG; Malm, O; Marques, RC | 1 |
Coleman, L; Geier, DA; Geier, MR; Gladfelter, B; Mumper, E | 1 |
Geier, DA; Geier, MR; Young, HA | 1 |
6 review(s) available for thimerosal and Child Development Deviations
Article | Year |
---|---|
Thiomersal-containing vaccines - a review of the current state of knowledge.
Topics: Autistic Disorder; Child; Developmental Disabilities; Drug Hypersensitivity; Evidence-Based Medicine; Humans; Preservatives, Pharmaceutical; Thimerosal; Vaccines | 2015 |
Making sense of epidemiological studies of young children exposed to thimerosal in vaccines.
Topics: Developmental Disabilities; Epidemiologic Studies; Female; Humans; Infant; Infant, Newborn; Neurotoxicity Syndromes; Pregnancy; Preservatives, Pharmaceutical; Thimerosal; Vaccines | 2010 |
Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.
Topics: Autistic Disorder; Child; Child Development Disorders, Pervasive; Developmental Disabilities; Diphtheria-Tetanus Vaccine; Diphtheria-Tetanus-Pertussis Vaccine; Ethylmercury Compounds; Half-Life; Humans; Methylmercury Compounds; Preservatives, Pharmaceutical; Research Design; Thimerosal | 2004 |
[Thiomersal and immunisations].
Topics: Adverse Drug Reaction Reporting Systems; Autistic Disorder; Child; Child, Preschool; Developmental Disabilities; Dose-Response Relationship, Drug; Germany; Humans; Infant; Mercury; Mercury Poisoning; Preservatives, Pharmaceutical; Risk; Risk Factors; Thimerosal; Vaccines | 2004 |
Vaccines, thimerosal, and neurodevelopmental outcomes.
Topics: Child; Developmental Disabilities; Humans; Infant; Preservatives, Pharmaceutical; Thimerosal; Vaccines | 2006 |
A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States.
Topics: Child, Preschool; Developmental Disabilities; Diphtheria-Tetanus-Pertussis Vaccine; Haemophilus Vaccines; Humans; Nervous System Diseases; Thimerosal; United States; Vaccination | 2006 |
1 trial(s) available for thimerosal and Child Development Deviations
Article | Year |
---|---|
Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines.
Topics: Child; Developmental Disabilities; Female; Humans; Infant; Male; Neuropsychological Tests; Preservatives, Pharmaceutical; Thimerosal; Time Factors; Vaccines | 2009 |
19 other study(ies) available for thimerosal and Child Development Deviations
Article | Year |
---|---|
Milestone achievement and neurodevelopment of rural Amazonian toddlers (12 to 24 months) with different methylmercury and ethylmercury exposure.
Topics: Brazil; Child, Preschool; Cross-Sectional Studies; Developmental Disabilities; Diet; Diet Surveys; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Ethylmercury Compounds; Female; Food Contamination; Hair; Humans; Infant; Language Development Disorders; Logistic Models; Male; Methylmercury Compounds; Mining; Preservatives, Pharmaceutical; Rural Health; Seafood; Thimerosal; Tin; Vaccines; Walking | 2014 |
Autism: 5 misconceptions that can complicate care.
Topics: Autistic Disorder; Behavior Therapy; Child; Developmental Disabilities; Diagnostic and Statistical Manual of Mental Disorders; Early Diagnosis; Humans; Independent Living; Mass Screening; Practice Guidelines as Topic; Preservatives, Pharmaceutical; Referral and Consultation; Social Participation; Societies, Medical; Thimerosal; Time-to-Treatment; Vaccines | 2014 |
A dose-response relationship between organic mercury exposure from thimerosal-containing vaccines and neurodevelopmental disorders.
Topics: Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Child; Child Development Disorders, Pervasive; Child, Preschool; Developmental Disabilities; Dose-Response Relationship, Drug; Female; Hepatitis B Vaccines; Humans; Infant; Male; Preservatives, Pharmaceutical; Thimerosal; Tic Disorders; United States | 2014 |
Regression of language and non-language skills in pervasive developmental disorders.
Topics: Adolescent; Adult; Age of Onset; Birth Order; Canada; Child; Child Development Disorders, Pervasive; Child, Preschool; Comorbidity; Developmental Disabilities; Female; Humans; Infant; Language Disorders; Male; Preservatives, Pharmaceutical; Severity of Illness Index; Sex Distribution; Thimerosal; Vaccination; Young Adult | 2009 |
Thimerosal-containing vaccines: evidence versus public apprehension.
Topics: Autistic Disorder; Child; Child, Preschool; Developmental Disabilities; Humans; Incidence; Preservatives, Pharmaceutical; Public Opinion; Risk Assessment; Thimerosal; United States; Vaccines | 2009 |
Thimerosal exposure (from tetanus-diphtheria vaccine) during pregnancy and neurodevelopment of breastfed infants at 6 months.
Topics: Adolescent; Adult; Breast Feeding; Developmental Disabilities; Diphtheria Toxoid; Female; Hair; Humans; Infant; Middle Aged; Neuropsychological Tests; Pregnancy; Prenatal Exposure Delayed Effects; Preservatives, Pharmaceutical; Regression Analysis; Tetanus Toxoid; Thimerosal; Young Adult | 2010 |
[Lack of association between thimerosal-containing vaccines and autism].
Topics: Autistic Disorder; Child; Child Welfare; Developmental Disabilities; Diphtheria-Tetanus-Pertussis Vaccine; Ethylmercury Compounds; Evidence-Based Medicine; Haemophilus Vaccines; Hepatitis B Vaccines; Humans; Thimerosal; Vaccines | 2011 |
Prenatal exposure to organomercury, thimerosal, persistently impairs the serotonergic and dopaminergic systems in the rat brain: implications for association with developmental disorders.
Topics: Animals; Brain; Brain Chemistry; Developmental Disabilities; Dopamine; Female; Hippocampus; Male; Neostriatum; Organomercury Compounds; Pregnancy; Prenatal Exposure Delayed Effects; Preservatives, Pharmaceutical; Rats; Rats, Wistar; Serotonin; Thimerosal | 2013 |
Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication.
Topics: Adverse Drug Reaction Reporting Systems; Child, Preschool; Databases, Factual; Developmental Disabilities; Diphtheria-Tetanus-acellular Pertussis Vaccines; Female; Humans; Infant; Male; Nervous System Diseases; Population Surveillance; Preservatives, Pharmaceutical; Risk Assessment; Thimerosal; United States; United States Food and Drug Administration | 2003 |
Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases.
Topics: Cohort Studies; Databases, Factual; Developmental Disabilities; Female; Health Maintenance Organizations; Humans; Infant; Infant, Newborn; Male; Preservatives, Pharmaceutical; Proportional Hazards Models; Retrospective Studies; Risk; Safety; Thimerosal; Vaccines | 2003 |
Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Causality; Cohort Studies; Developmental Disabilities; Diet; Diphtheria-Tetanus Vaccine; Diphtheria-Tetanus-Pertussis Vaccine; Female; Fishes; Humans; Infant; Logistic Models; Male; Motor Skills; Multivariate Analysis; Pregnancy; Prenatal Exposure Delayed Effects; Preservatives, Pharmaceutical; Prospective Studies; Speech Disorders; Thimerosal | 2004 |
Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.
Topics: Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Cohort Studies; Developmental Disabilities; Diphtheria-Tetanus Vaccine; Diphtheria-Tetanus-Pertussis Vaccine; Female; Follow-Up Studies; Humans; Infant; Language Disorders; Male; Multivariate Analysis; Preservatives, Pharmaceutical; Proportional Hazards Models; Retrospective Studies; Speech Disorders; Survival Analysis; Thimerosal; Tics | 2004 |
Time of perinatal immunization, thimerosal exposure and neurodevelopment at 6 months in breastfed infants.
Topics: Body Weight; Brazil; Breast Feeding; Developmental Disabilities; Ethylmercury Compounds; Female; Hepatitis B Vaccines; Humans; Immunization Schedule; Infant, Newborn; Male; Maximum Tolerated Dose; Neuropsychological Tests; Preservatives, Pharmaceutical; Thimerosal; Time Factors | 2007 |
Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.
Topics: Child; Child Development; Developmental Disabilities; Environmental Exposure; Ethylmercury Compounds; Female; Humans; Immunoglobulins; Infant; Infant, Newborn; Intelligence; Male; Neuropsychological Tests; Pregnancy; Prenatal Exposure Delayed Effects; Preservatives, Pharmaceutical; Regression Analysis; Thimerosal; Vaccines | 2007 |
Principal component analysis and discrimination of variables associated with pre- and post-natal exposure to mercury.
Topics: Adolescent; Adult; Brazil; Breast Feeding; Child Development; Cohort Studies; Developmental Disabilities; Diphtheria-Tetanus-Pertussis Vaccine; Female; Hepatitis B Vaccines; Humans; Immunization Schedule; Infant; Mercury; Methylmercury Compounds; Middle Aged; Pregnancy; Prenatal Exposure Delayed Effects; Principal Component Analysis; Thimerosal; Young Adult | 2008 |
Mercury in vaccines and developmental problems: the latest research.
Topics: Child; Developmental Disabilities; Humans; Preservatives, Pharmaceutical; Thimerosal; Vaccines | 2007 |
Neurodevelopmental disorders, maternal Rh-negativity, and Rho(D) immune globulins: a multi-center assessment.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Child; Child Development Disorders, Pervasive; Child, Preschool; Developmental Disabilities; Female; Humans; Male; Mothers; Pregnancy; Prenatal Exposure Delayed Effects; Preservatives, Pharmaceutical; Retrospective Studies; Rh-Hr Blood-Group System; Rho(D) Immune Globulin; Risk Factors; Thimerosal | 2008 |
Infants' lead exposure and potential confounders of neurocognitive status.
Topics: Breast Feeding; Child Development; Developmental Disabilities; Diphtheria-Tetanus-Pertussis Vaccine; Female; Hepatitis B Vaccines; Humans; Infant; Infant, Newborn; Lead; Poland; Pregnancy; Prenatal Exposure Delayed Effects; Thimerosal | 2008 |
Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink.
Topics: Adolescent; Child; Child Development Disorders, Pervasive; Child, Preschool; Cohort Studies; Developmental Disabilities; Evaluation Studies as Topic; Female; Humans; Infant; Male; Medical Records Systems, Computerized; Preservatives, Pharmaceutical; Proportional Hazards Models; Retrospective Studies; Thimerosal; Vaccines | 2008 |